Playground Global — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Amber Bio is a biotechnology company developing a novel RNA writing platform capable of multi-kilobase gene edits that can treat multiple mutations across patients with a single product.
AI & Machine LearningBiotechDeep Tech
Jacob Borrajo, PhD(Founder and CEO)
Co-investorsAndreessen HorowitzHummingbird Ventures
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
TIMOTHY CRAVEN(Executive Officer, Director)TOBY PASSIOURA(Executive Officer, Director)Tim Craven(CEO)Toby Passioura(CSO)Glen McIntyre(COO)GLEN MCINTYRE(Executive Officer, Director)
PartnerBenjamin Kim· led
Board seatMatt Hershenson· per SEC Form D
Co-investorsCivilization Ventures Management, LlcMRL Ventures FundvenBio PartnersAxial VCvenBio Global Strategic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.